Calamos Advisors
JNJ icon

Calamos Advisors’s Johnson & Johnson JNJ Stock Holding History

Calamos Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-302,000
Closed -$40M – 637
2017
Q2 		$40M Buy
+302,000
New +$38.5M 0.3% 89

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Calamos Advisors's JNJ Position: Q2 2026 in Review

Calamos Advisors reduced its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, selling an estimated $29.3M and leaving 647,222 shares worth $164M. The position accounts for 0.55% of the portfolio, ranked #30.

Calamos Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $237M in Q3 2018. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Calamos Advisors held 647,222 shares of Johnson & Johnson worth $164M as of Q2 2026.
  • Calamos Advisors sold 125,878 Johnson & Johnson shares in Q2 2026, an estimated $29.3M.
  • Johnson & Johnson made up 0.55% of Calamos Advisors's portfolio in Q2 2026, its #30 holding.
  • Calamos Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Calamos Advisors's Johnson & Johnson position peaked at $237M in Q3 2018.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.